Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Principia Biopharma Inc. | prnb-ex321_469.htm |
| EX-31.2 - EX-31.2 - Principia Biopharma Inc. | prnb-ex312_470.htm |
| EX-31.1 - EX-31.1 - Principia Biopharma Inc. | prnb-ex311_471.htm |
| EX-10.18 - EX-10.18 - Principia Biopharma Inc. | prnb-ex1018_468.htm |
| EX-4.2 - EX-4.2 - Principia Biopharma Inc. | prnb-ex42_222.htm |
| 10-K - 10-K - Principia Biopharma Inc. | prnb-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statement (Form S-8 No. 333-227389) pertaining to the Amended and Restated 2008 Equity Incentive Plan, the 2018 Equity Incentive Plan and the 2018 Employee Stock Purchase Plan of Principia Biopharma Inc., |
|
|
(2) |
Registration Statement (Form S-8 No. 333-231263) pertaining to the 2018 Equity Incentive Plan and the 2018 Employee Stock Purchase Plan of Principia Biopharma Inc., and |
|
|
(3) |
Registration Statement (Form S-3 No. 333-234038) of Principia Biopharma Inc. and the related Prospectus; |
of our report dated March 10, 2020, with respect to the consolidated financial statements of Principia Biopharma Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Redwood City, California
March 10, 2020